https://www.selleckchem.com/pr....oducts/leptomycinb.h
, we found no evidence for large differences between COVID-19 and non-COVID ARDS. Many key clinical features of severe COVID-19 were similar to those of non-COVID-19 ARDS, including respiratory physiology and clinical outcomes, although our sample size precludes definitive conclusions. Further studies are needed to define COVID-19-specific pathophysiology before deviation from evidence-based treatment practices can be recommended. There is a shortage of studies evaluating the effect of prevalent use of immunomodulators (IMMs) and bi
Like
Comment
Share
